Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
3.910
-0.100 (-2.49%)
At close: Jul 25, 2025, 4:00 PM
4.030
+0.120 (3.07%)
After-hours: Jul 25, 2025, 7:43 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $121.15 million as of July 25, 2025. Its market cap has decreased by -29.11% in one year.
Market Cap
121.15M
Enterprise Value
62.34M
1-Year Change
-29.11%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $121.15M, a decrease of -65.98%. That is a compound annual growth rate of -56.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 121.10M | 40.98% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.06B |
| Johnson & Johnson | 407.97B |
| AbbVie | 337.08B |
| Novo Nordisk | 313.06B |
| UnitedHealth Group | 252.71B |
| AstraZeneca | 228.91B |
| Novartis AG | 227.81B |
| Abbott Laboratories | 218.59B |